People

Kathy O’Connor represents pharmaceutical, biotechnology, medical device and consumer product companies in complex product liability and commercial claims, consumer fraud class actions, licensing and co-development disputes, and government investigations. Her practice has a particular focus on complex matters that involve concurrent civil and government actions. Clients routinely call upon Kathy to assist them with the management and mitigation of risk associated with their products, leveraging her previous experience serving as an in-house lawyer at Merck.

Kathy is regularly recognized as a leading practitioner by lawyer ranking entities such as Euromoney Expert Guides' Women in Business Law and The Legal 500, which singled out her product liability and mass torts defense work. She served as the co-chair of her previous firm’s Life Sciences practice.

Full Bio

Credentials

J.D., Boston University School of Law

B.A., Florida State University, English Department Award for Outstanding Achievement, Selby Scholarship for Academic Excellence

New York

Supreme Court of the United States

U.S. District Court for the Southern District of New York

Recognized as an expert for work on product liability matters


Euromoney’s Expert Guides, 2014 – 2016

Recognized as “Highly Regarded” in product liability and mass torts defense


Legal 500, 2010 – 2011

Editor-in-Chief of Annual Review of Banking Law


Boston University School of Law

Icon close

Close

Recognition

Recognized as an expert for work on product liability matters


Euromoney’s Expert Guides, 2014 – 2016

Recognized as “Highly Regarded” in product liability and mass torts defense


Legal 500, 2010 – 2011

Editor-in-Chief of Annual Review of Banking Law


Boston University School of Law

News

In the News · Source: The American Lawyer, Law360, Reuters, Bloomberg Big Law Business, Bloomberg Law, CDR and Law.com

February 3, 2020
Pharma and healthcare partners Morty Dubin, John Ewald, Kristen Fournier and Kathy O’Connor join the firm's Trial and Global Disputes practice group in New York

View all

Matters

Defended pharmaceutical, consumer product and medical device companies in hundreds of product liability lawsuits

Defended pharmaceutical companies in dozens of consumer fraud class action cases

Participated in a multi-year DOJ investigation into allegations of off-label promotion

See more
Icon close

Close

Matters

Defended pharmaceutical, consumer product and medical device companies in hundreds of product liability lawsuits

Defended pharmaceutical companies in dozens of consumer fraud class action cases

Participated in a multi-year DOJ investigation into allegations of off-label promotion

Represented and advised life sciences companies in disputes involving joint collaboration and development agreements

Conducted several internal investigations relating to whistleblower allegations of off-label promotion

Provided strategic advice to a major pharmaceutical company on managing risk associated with FDA inquiries relating to a significant product and responsibility for ensuing litigation

Participated in FCPA investigations on behalf of pharmaceutical companies

Prepared key company executives for testimony in a series of government investigations and inquiries of the company

Advised European life sciences companies on managing litigation risk and avoiding fraud and abuse risk

Advised many mobile medical technologies companies on risk and marketing issues

News

In the News · Source: The American Lawyer, Law360, Reuters, Bloomberg Big Law Business, Bloomberg Law, CDR and Law.com

February 3, 2020
Pharma and healthcare partners Morty Dubin, John Ewald, Kristen Fournier and Kathy O’Connor join the firm's Trial and Global Disputes practice group in New York

View all

Matters

Defended pharmaceutical, consumer product and medical device companies in hundreds of product liability lawsuits

Defended pharmaceutical companies in dozens of consumer fraud class action cases

Participated in a multi-year DOJ investigation into allegations of off-label promotion

See more
Icon close

Close

Matters

Defended pharmaceutical, consumer product and medical device companies in hundreds of product liability lawsuits

Defended pharmaceutical companies in dozens of consumer fraud class action cases

Participated in a multi-year DOJ investigation into allegations of off-label promotion

Represented and advised life sciences companies in disputes involving joint collaboration and development agreements

Conducted several internal investigations relating to whistleblower allegations of off-label promotion

Provided strategic advice to a major pharmaceutical company on managing risk associated with FDA inquiries relating to a significant product and responsibility for ensuing litigation

Participated in FCPA investigations on behalf of pharmaceutical companies

Prepared key company executives for testimony in a series of government investigations and inquiries of the company

Advised European life sciences companies on managing litigation risk and avoiding fraud and abuse risk

Advised many mobile medical technologies companies on risk and marketing issues

News

In the News · Source: The American Lawyer, Law360, Reuters, Bloomberg Big Law Business, Bloomberg Law, CDR and Law.com

February 3, 2020
Pharma and healthcare partners Morty Dubin, John Ewald, Kristen Fournier and Kathy O’Connor join the firm's Trial and Global Disputes practice group in New York

View all

Credentials

J.D., Boston University School of Law

B.A., Florida State University, English Department Award for Outstanding Achievement, Selby Scholarship for Academic Excellence

New York

Supreme Court of the United States

U.S. District Court for the Southern District of New York

Recognized as an expert for work on product liability matters


Euromoney’s Expert Guides, 2014 – 2016

Recognized as “Highly Regarded” in product liability and mass torts defense


Legal 500, 2010 – 2011

Editor-in-Chief of Annual Review of Banking Law


Boston University School of Law

Icon close

Close

Recognition

Recognized as an expert for work on product liability matters


Euromoney’s Expert Guides, 2014 – 2016

Recognized as “Highly Regarded” in product liability and mass torts defense


Legal 500, 2010 – 2011

Editor-in-Chief of Annual Review of Banking Law


Boston University School of Law